| Literature DB >> 35967570 |
Hiwot Dejene1, Derara Girma1, Leta Adugna Geleta1, Elsabeth Legesse1.
Abstract
Background: Globally, vaccination is one of the most cost-effective interventions in promoting child survival, preventing 2-3 million child deaths annually from vaccine-preventable diseases (VPDs). In Ethiopia, timely vaccination is stated as key to the prevention of unnecessary childhood mortality from measles, pneumonia, diarrheal diseases, and other VPDs. However, Ethiopia ranked fifth among the ten countries with the most unprotected children. Furthermore, previous vaccine timeliness studies produced widely disparate results. As a result, it was suggested that more research be conducted to investigate the potential factors behind the high proportion of untimely vaccination. Therefore, this study was intended to explore the association between different factors and the proportion of vaccination timeliness administered under the Expanded Program on Immunization in Debre Libanos district, Ethiopia.Entities:
Keywords: 12-23 months; Debre Libanos; Ethiopia; North Shewa Zone; children; vaccination timeliness
Year: 2022 PMID: 35967570 PMCID: PMC9363667 DOI: 10.3389/fped.2022.867846
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
National and WHO recommended vaccination timelines.
| Vaccine | WHO recommendation | Operational definition | ||
| Minimum age | Minimum interval | Delayed | Early | |
| BCG and OPV 0 | At birth | 4 weeks | >4 weeks | _ |
| DTP-HepB1-Hib1, OPV1, PCV1, Rota1 | 6 weeks | 4 weeks | >10 weeks | <42 days |
| DTP-HepB2-Hib2, OPV2, PCV2, Rota2 | 10 weeks | 4 weeks | >14 weeks | <70 days |
| DTP-HepB3-Hib3, OPV3, PCV3, IPV | 14 weeks | 4 weeks | >18 weeks | <98 days |
| Measles first dose | 9 months | 4 weeks | >10 month | <270 days |
| Measles second dose | 15-18 months | |||
Sociodemographic characteristics of the respondents and the child for vaccination timeliness and associated factors among children aged 12–23 months in Debre Libanos district North Shewa Zone, Oromia Regional State, Ethiopia 2021.
| Variables | Categories | Frequency | Percentage |
| Sex of the child | Male | 169 | 40.9 |
| Female | 244 | 59.1 | |
| Residence | Urban | 125 | 30.3 |
| Rural | 288 | 69.7 | |
| Mother/caregiver age | 15-24 | 48 | 11.6 |
| 25-35 | 220 | 53.3 | |
| > 35 | 145 | 35.1 | |
| Marital status of the mother/caregiver | Married | 277 | 67.1 |
| Divorced | 87 | 21.1 | |
| Single | 49 | 11.9 | |
| Educational status of mother/caregiver | No formal education | 111 | 26.9 |
| Primary education (1-8) | 150 | 36.3 | |
| Secondary and higher education | 152 | 36.8 | |
| Educational status of the father | No formal education | 38 | 13.7 |
| Primary education (1-8) | 120 | 43.3 | |
| Secondary and higher education | 119 | 43.0 | |
| Occupational status of mother/caregiver | Housewife | 134 | 32.4 |
| Farmer | 145 | 36.1 | |
| Employed {government/non-government} | 114 | 26.7 | |
| Merchant | 20 | 4.8 | |
| Occupational status of the father | Farmer | 119 | 43 |
| Employed {government/non-government} | 81 | 19.6 | |
| Merchant | 77 | 18.6 | |
| Birth season of the child | Summer | 68 | 16.5 |
| Autumn | 104 | 25.2 | |
| Spring | 120 | 29.1 | |
| Winter | 121 | 29.3 | |
| Birth order of the child | 1 | 122 | 29.5 |
| 2-4 | 228 | 55.2 | |
| ≥ 5 | 63 | 15.3 | |
| Household wealth index | Lowest wealth index | 130 | 31.5 |
| Middle wealth index | 125 | 30.3 | |
| Highest wealth index | 158 | 38.2 |
Obstetric related factors for vaccination timeliness and associated factors among children aged 12–23 months in Debre Libanos district North Shewa Zone, Oromia Regional State, Ethiopia 2021.
| Variables | Categories | Number | Percentage % |
| Number of pregnancies | Primigravida | 54 | 13.1 |
| Multigravida | 334 | 80.9 | |
| Grand multigravida | 25 | 6.0 | |
| Number of alive children | 1 child | 127 | 30.8 |
| 2-4 children | 214 | 51.8 | |
| > = 5 children | 72 | 17.4 | |
| Last pregnancy status | Planned | 330 | 79.9 |
| Unplanned | 83 | 20.1 | |
| ANC visit | Yes | 331 | 80.1 |
| No | 82 | 19.9 | |
| Number of ANC visit | 1 | 129 | 38.9 |
| 2 | 144 | 43.5 | |
| ≥ 3 | 58 | 17.6 | |
| TT dose received during the pregnancy | No | 72 | 17.4 |
| One | 194 | 47.0 | |
| Two or more | 147 | 35.6 | |
| PNC service utilization | Yes | 326 | 78.9 |
| No | 87 | 21.1 | |
| Place of delivery | At health facility | 316 | 76.5 |
| Home | 97 | 23.5 |
FIGURE 1Knowledge about vaccination among mothers/caregivers.
FIGURE 2Vaccination hesitancy among mothers/caregivers.
Access-related factors for vaccination timeliness and associated factors among children aged 12–23 months in Debre Libanos district North Shewa Zone, Oromia Regional State, Ethiopia 2021.
| Variables | Categories | Number | Percentage % |
| Time taken to vaccination site | < 30 min | 245 | 59.3 |
| ≥ 30 min | 168 | 40.7 | |
| Mode of transportation | On foot | 169 | 40.9 |
| By vehicle | 32 | 7.7 | |
| By bus | 31 | 7.5 | |
| By cart/ animal | 181 | 43.8 | |
| Source of information | Mobile | 67 | 16.2 |
| Television | 35 | 8.5 | |
| Radio | 43 | 10.4 | |
| Health extension worker | 268 | 64.9 | |
| Place of vaccination received | Health center | 214 | 51.8 |
| Health post | 199 | 48.2 |
FIGURE 3Vaccination timeliness among children aged 12-23 months.
FIGURE 4Vaccination timeliness for specific antigen among children aged 12-23 months.
FIGURE 5Perceived reasons for not vaccinating children timely.
Factors associated with vaccination timeliness among children aged 12–23 months in Debre Libanos district, North Shewa Zone, Oromia Region State, Ethiopia 2021.
| Variable | Categories | Vaccination timeliness | COR (95% CI) | AOR (95% CI) | |
| Timely n (%) | Untimely n (%) | ||||
| Residence | Urban | 54 (43.2) | 71 (56.8) | Ref | Ref |
| Rural | 85 (29.5) | 203 (70.5) | 1.82 [1.17-2.81] | 1.34 [0.70-2.58] | |
| Sex of the child | Male | 29 (17.2) | 140 (82.8) | Ref | Ref |
| Female | 110 (45.1) | 134 (54.9) | 3.96 [2.47-6.35] | 2.91 [1.58-5.35] | |
| Educational status of the mother/caregiver | No formal education | 13 (11.7) | 98 (88.3) | Ref | Ref |
| Primary | 65 (43.3) | 85 (56.7) | 5.76 [2.97-11.18] | 6.33 [2.66-15.06] | |
| Secondary and above | 61 (40.1) | 91 (59.9) | 5.05 [2.60-9.81] | 5.61 [2.41-13.04] | |
| Marital status of the mother/caregiver | Married | 120 (43.3) | 157 (56.7) | 3.39 [1.58-7.27] | 2.73 [0.99-7.49] |
| Divorced | 10 (11.5) | 77 (88.5) | 0.57 [0.22-1.54] | 0.36 [0.59-1.38] | |
| Single | 9 (18.4) | 40 (81.6) | Ref | Ref | |
| Birth order | 1 | 60 (47.2) | 67 (52.8) | 3.07 [1.45-6.46] | 0.48 [0.10-2.27] |
| 2-4 | 57 (26.6) | 157 (73.4) | 2.55 [1.26-5.17] | 2.81 [0.99-17.83] | |
| ≥ 5 | 22(30.6) | 50 (69.4) | Ref | Ref | |
| Knowledge about vaccination | Sufficient knowledge | 109 (39.9) | 164 (60.1) | 2.44 [1.52-3.90] | 3.46 [1.87-6.38] |
| Insufficient knowledge | 30 (21.4) | 110 (78.6) | Ref | Ref | |
| Vaccination hesitancy | Most hesitant | 32 (20.8) | 122 (79.2) | Ref | Ref |
| Middle hesitant | 70 (38.7) | 111 (61.3) | 2.40 [1.47-3.92] | 1.89 [1.05-3.58] | |
| Least hesitant | 37 (47.4) | 41 (52.6) | 3.44 [1.91-6.21] | 3.35 [1.51-7.41] | |
| Number of alive children | 1 child | 60 (47.2) | 67 (52.8) | 2.04 [1.11-3.74] | 3.47 [0.26-9.51] |
| 2-4 children | 57 (26.6) | 157 (73.4) | 0.83 [0.46-1.48] | 0.31 [0.13-0.73] | |
| > = 5 children | 22(30.6) | 50 (69.4) | Ref | Ref | |
| Last pregnancy status | Planned | 128 (38.8) | 202 (61.2) | 4.15 [2.12-8.12] | 3.71 [0.63-5.42] |
| Unplanned | 11 (13.3) | 72 (86.7) | Ref | Ref | |
| Utilization of ANC | Yes | 123 (37.2) | 208 (62.8) | 2.44 [1.35-4.40] | 2.89 [1.32-6.33] |
| No | 16 (19.5) | 66 (80.5) | Ref | Ref | |
| Utilization of TT dose | No | 20 (27.8) | 52 (72.2) | Ref | Ref |
| 1 dose only | 60 (30.9) | 134 (69.1) | 1.16 [0.64-2.12] | 1.22 [0.54-2.78] | |
| 2 and more dose | 59 (40.1) | 88 (59.9) | 1.74 [0.95-3.22] | 1.73 [0.74-4.05] | |
| Place of delivery | Home | 22 (22.7) | 75 (77.3) | Ref | Ref |
| At health facility | 117 (37.0) | 199 (63.0) | 2.00 [1.18-3.39] | 4.32 [1.95-9.59] | |
| Utilization of PNC | Yes | 123 (37.7) | 203 (62.3) | 2.69 [1.49-4.84] | 2.23 [0.76-6.51] |
| No | 16 (18.4) | 71 (81.6) | Ref | Ref | |
*Statistically significant at P-value of ≤0.05, **statistically significant at P-value of <0.001.